Literature DB >> 14999097

Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes.

Keigo Machida1, Kevin T-N Cheng, Vicky M-H Sung, Shigetaka Shimodaira, Karen L Lindsay, Alexandra M Levine, Ming-Yang Lai, Michael M C Lai.   

Abstract

Hepatitis C virus (HCV) is a nonretroviral oncogenic RNA virus, which is frequently associated with hepatocellular carcinoma (HCC) and B cell lymphoma. We demonstrated here that acute and chronic HCV infection caused a 5- to 10-fold increase in mutation frequency in Ig heavy chain, BCL-6, p53, and beta-catenin genes of in vitro HCV-infected B cell lines and HCV-associated peripheral blood mononuclear cells, lymphomas, and HCCs. The nucleotide-substitution pattern of p53 and beta-catenin was different from that of Ig heavy chain in HCV-infected cells, suggesting two different mechanisms of mutation. In addition, the mutated protooncogenes were amplified in HCV-associated lymphomas and HCCs, but not in lymphomas of nonviral origin or HBV-associated HCC. HCV induced error-prone DNA polymerase zeta, polymerase iota, and activation-induced cytidine deaminase, which together, contributed to the enhancement of mutation frequency, as demonstrated by the RNA interference experiments. These results indicate that HCV induces a mutator phenotype and may transform cells by a hit-and-run mechanism. This finding provides a mechanism of oncogenesis for an RNA virus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999097      PMCID: PMC384729          DOI: 10.1073/pnas.0303971101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  DNA synthesis errors associated with double-strand-break repair.

Authors:  J N Strathern; B K Shafer; C B McGill
Journal:  Genetics       Date:  1995-07       Impact factor: 4.562

2.  Cells strongly expressing Ig(kappa) transgenes show clonal recruitment of hypermutation: a role for both MAR and the enhancers.

Authors:  B Goyenechea; N Klix; J Yélamos; G T Williams; A Riddell; M S Neuberger; C Milstein
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

3.  Analysis of the frequency and pattern of somatic mutations within nonproductively rearranged human variable heavy chain genes.

Authors:  T Dörner; H P Brezinschek; R I Brezinschek; S J Foster; R Domiati-Saad; P E Lipsky
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

4.  Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma.

Authors:  A Migliazza; S Martinotti; W Chen; C Fusco; B H Ye; D M Knowles; K Offit; R S Chaganti; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

5.  A role for REV3 in mutagenesis during double-strand break repair in Saccharomyces cerevisiae.

Authors:  S L Holbeck; J N Strathern
Journal:  Genetics       Date:  1997-11       Impact factor: 4.562

6.  Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas.

Authors:  M Ivanovski; F Silvestri; G Pozzato; S Anand; C Mazzaro; O R Burrone; D G Efremov
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

7.  Hepatitis C virus infection in patients with non-Hodgkin's lymphoma.

Authors:  C Ferri; F Caracciolo; A L Zignego; L La Civita; M Monti; G Longombardo; F Lombardini; F Greco; E Capochiani; A Mazzoni
Journal:  Br J Haematol       Date:  1994-10       Impact factor: 6.998

8.  Binding of hepatitis C virus to CD81.

Authors:  P Pileri; Y Uematsu; S Campagnoli; G Galli; F Falugi; R Petracca; A J Weiner; M Houghton; D Rosa; G Grandi; S Abrignani
Journal:  Science       Date:  1998-10-30       Impact factor: 47.728

9.  Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders.

Authors:  F Silvestri; C Pipan; G Barillari; F Zaja; R Fanin; L Infanti; D Russo; E Falasca; G A Botta; M Baccarani
Journal:  Blood       Date:  1996-05-15       Impact factor: 22.113

10.  BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci.

Authors:  L Pasqualucci; A Migliazza; N Fracchiolla; C William; A Neri; L Baldini; R S Chaganti; U Klein; R Küppers; K Rajewsky; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

View more
  128 in total

1.  Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes.

Authors:  Lucia Kato; Nasim A Begum; A Maxwell Burroughs; Tomomitsu Doi; Jun Kawai; Carsten O Daub; Takahisa Kawaguchi; Fumihiko Matsuda; Yoshihide Hayashizaki; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation.

Authors:  Keigo Machida; Kevin T-H Cheng; Chao-Kuen Lai; King-Song Jeng; Vicky M-H Sung; Michael M C Lai
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  High-resolution characterization of a hepatocellular carcinoma genome.

Authors:  Yasushi Totoki; Kenji Tatsuno; Shogo Yamamoto; Yasuhito Arai; Fumie Hosoda; Shumpei Ishikawa; Shuichi Tsutsumi; Kohtaro Sonoda; Hirohiko Totsuka; Takuya Shirakihara; Hiromi Sakamoto; Linghua Wang; Hidenori Ojima; Kazuaki Shimada; Tomoo Kosuge; Takuji Okusaka; Kazuto Kato; Jun Kusuda; Teruhiko Yoshida; Hiroyuki Aburatani; Tatsuhiro Shibata
Journal:  Nat Genet       Date:  2011-04-17       Impact factor: 38.330

Review 4.  The dark side of activation-induced cytidine deaminase: relationship with leukemia and beyond.

Authors:  Kazuo Kinoshita; Taichiro Nonaka
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

5.  Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1/Mre11/Rad50 DNA repair pathway in monocytes and hepatocytes.

Authors:  Keigo Machida; George McNamara; Kevin T-H Cheng; Jeffrey Huang; Chun-Hsiang Wang; Lucio Comai; Jing-Hsiung James Ou; Michael M C Lai
Journal:  J Immunol       Date:  2010-10-25       Impact factor: 5.422

Review 6.  Hepatitis C virus and lymphoma.

Authors:  D S Viswanatha; A Dogan
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

7.  Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial).

Authors:  Marta Epeldegui; Jeannette Y Lee; Anna C Martínez; Daniel P Widney; Larry I Magpantay; Deborah Regidor; Ronald Mitsuyasu; Joseph A Sparano; Richard F Ambinder; Otoniel Martínez-Maza
Journal:  Clin Cancer Res       Date:  2015-09-17       Impact factor: 12.531

Review 8.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

Review 9.  Molecular mechanisms of viral oncogenesis in humans.

Authors:  Nathan A Krump; Jianxin You
Journal:  Nat Rev Microbiol       Date:  2018-11       Impact factor: 60.633

10.  B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers.

Authors:  Thinh Huy Tran; Mikiyo Nakata; Keiichiro Suzuki; Nasim A Begum; Reiko Shinkura; Sidonia Fagarasan; Tasuku Honjo; Hitoshi Nagaoka
Journal:  Nat Immunol       Date:  2009-12-06       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.